CompletedNot Applicable

tACS Treatment for Cognitive Impairments in Methamphetamine Addicts

China68 participantsStarted 2023-12-30

Plain-language summary

1. To evaluate the cognitive function of methamphetamine Patients. 2. Investigate the pathological mechanism of methamphetamine patients from the aspects of EEG and biology; 3. The investigators investigated the effects of transcranial alternating current stimulation (tACS) on cognitive impairments in methamphetamine patients

Who can participate

Age range18 Years – 55 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical diagnosis diagnosis of methamphetamine use disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) * None of participants had mixed use of other drugs * None of participants had physical disability * None of participants had acute physical or mental illness, hallucinations, acute withdrawal symptoms * None of participants were receiving any medical treatment Exclusion Criteria: * Intracranial hypertension * Cranial defects * Tumors * Serious physical illnesses (e.g., cardiovascular, liver, kidney, gastrointestinal disorders) * Infectious diseases * Immune system disorders

What they're measuring

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

Timeframe: Baseline, week 3

ERP components associated with cognitive function

Timeframe: Baseline, week 3

Condition stop signal task

Timeframe: Baseline, week 3

Neural oscillations associated with cognitive function

Timeframe: Baseline, week 3

Functional connection of brain region associated with cognitive function

Timeframe: Baseline, week 3

Microstate associated with cognitive function

Timeframe: Baseline, week 3

Neural Dynamic Coding of brain region associated with cognitive function

Timeframe: baseline, week 3

The effect of oxidative stress system on cognitive function

Timeframe: Baseline, week 3

Trial details

NCT IDNCT06292156

SponsorBeijing HuiLongGuan Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-30

View on ClinicalTrials.gov More Methamphetamine Abuse trials

Plain-language summary

Who can participate

Age range18 Years – 55 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

Timeframe: Baseline, week 3

ERP components associated with cognitive function

Timeframe: Baseline, week 3

Condition stop signal task

Timeframe: Baseline, week 3

Neural oscillations associated with cognitive function

Timeframe: Baseline, week 3

Functional connection of brain region associated with cognitive function

Timeframe: Baseline, week 3

Microstate associated with cognitive function

Timeframe: Baseline, week 3

Neural Dynamic Coding of brain region associated with cognitive function

Timeframe: baseline, week 3

The effect of oxidative stress system on cognitive function

Timeframe: Baseline, week 3